2025-08-19 - Analysis Report
Okay, here's an analysis of Johnson & Johnson (JNJ) based on the data you provided, presented in an easy-to-understand format.

## JNJ (Johnson & Johnson) Stock Analysis

Johnson & Johnson is a global healthcare company engaged in the research and development, manufacture, and sale of a broad range of products in the healthcare field.

### 1. Performance vs. S&P 500 (VOO)

*   **JNJ Cumulative Return:** 29.64%
*   **VOO Cumulative Return:** 100.85%
*   **Spread:** -68.9 (JNJ is lagging behind VOO)
*   **Relative Spread Position:** 9.8 (JNJ is near the lower end of its historical performance range compared to VOO)

**Analysis:** JNJ has significantly underperformed the S&P 500 over the period analyzed. The relative spread position indicates that this underperformance is near the bottom of its historical range.

**Alpha, Beta Analysis Table:**

| Year       | CAGR     | MDD   | Alpha   | Beta | Cap(B) |
|------------|----------|-------|---------|------|--------|
| 2015-2017  | 28.0%    | 56.1% | -1.0%   | -0.0 | 336.5  |
| 2016-2018  | 8.0%     | 56.6% | -10.0%  | 0.0  | 310.8  |
| 2017-2019  | 18.0%    | 56.6% | -12.0%  | 0.7  | 351.3  |
| 2018-2020  | 12.0%    | 59.2% | -8.0%   | 0.3  | 379.0  |
| 2019-2021  | 32.0%    | 59.6% | -16.0%  | 0.2  | 412.0  |
| 2020-2022  | 7.0%     | 61.4% | 5.0%    | 0.2  | 425.4  |
| 2021-2023  | -15.0%   | 61.4% | -33.0%  | 0.4  | 377.5  |
| 2022-2024  | -35.0%   | 61.4% | -61.0%  | 0.3  | 348.3  |
| 2023-2025  | 2.0%     | 70.1% | -50.0%  | 0.2  | 424.5  |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate shows fluctuating performance, with negative growth in recent periods.
*   **MDD:** The Maximum Drawdown indicates significant potential for loss, especially in recent years.
*   **Alpha:** The negative Alpha values suggest that JNJ has consistently underperformed its benchmark on a risk-adjusted basis for many periods.
*   **Beta:** The Beta values are generally low, indicating that JNJ's price is not highly sensitive to market movements.

### 2. Recent Price Action

*   **Current Price:** 176.25
*   **Previous Close:** 176.64
*   **Change:** -0.22 (Slight decrease)
*   **5-day Moving Average:** 174.96
*   **20-day Moving Average:** 170.72
*   **60-day Moving Average:** 160.41

**Analysis:** The stock price has experienced a slight decrease recently.  The price is above all three moving averages, which *could* be interpreted as a short-term bullish signal, but consider this in context of the other factors.

### 3. Technical Indicators & Outlook

*   **Market Risk Indicator (MRI):** 0.3285 (Low Risk)
*   **RSI:** 71.83 (Overbought)
*   **PPO:** 0.1011
*   **Hybrid Signal:** Cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.34)
*   **Recent Relative Spread Change (20-day):** -1.1 (Short-term Decrease)
*   **Expected Return:** -281.1% (Significant underperformance vs. S&P 500 expected over 2+ years)

**Analysis:**

*   **MRI:** Indicates a low-risk environment.
*   **RSI:** The RSI suggests the stock is overbought, which could precede a price correction.
*   **Hybrid Signal:** The hybrid signal suggests a Buy with Caution.
*   **Recent Relative Spread Change:** Suggests a short-term decrease in relative performance.
*   **Expected Return:** The very negative expected return suggests caution for long-term investment, indicating significant expected underperformance compared to the S&P 500. The small price change (-0.22) doesn't suggest any immediate, major volatility event.

### 4. Recent News & Events

*   **[2025-08-18]:** JNJ in the news due to major business developments, regulatory changes, or market events.
*   **[2025-08-15]:** Analysts discussing JNJ's performance in the context of industry trends and global economic factors.
*   **[2025-08-17]:** JNJ's stock showing notable volatility.
*   **[2025-08-19]:** Market experts highlighting both risks and opportunities for JNJ.

**Analysis:** Recent news points to potential volatility and significant events influencing the stock. Investors should monitor company announcements and industry news closely.

### 5. Recent Earnings Analysis

| 날짜         | EPS  | 매출          |
|--------------|------|---------------|
| 2025-07-24   | 2.3  | 23.74 B$      |
| 2025-04-23   | 4.57 | 21.89 B$      |
| 2024-10-23   | 1.12 | 22.47 B$      |
| 2024-07-25   | 1.95 | 22.45 B$      |
| 2025-07-24   | 1.95 | 22.45 B$      |

**Analysis:** The earnings per share (EPS) and revenue figures have fluctuated. While revenue has generally been strong, EPS has varied. The duplication of the 2025-07-24 row suggests a potential data error.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-06-30   | $23.74B   | 67.87%        |
| 2025-03-31   | $21.89B   | 66.40%        |
| 2024-12-31   | $22.52B   | 68.35%        |
| 2024-09-30   | $22.47B   | 69.01%        |
| 2024-06-30   | $22.45B   | 69.40%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE       |
|--------------|-----------|-----------|
| 2025-06-30   | $78.47B   | 7.06%     |
| 2025-03-31   | $78.11B   | 14.08%    |
| 2024-12-31   | $71.49B   | 4.80%     |
| 2024-09-30   | $70.16B   | 3.84%     |
| 2024-06-30   | $71.54B   | 6.55%     |

**Analysis:**

*   **Revenue:** Revenue has been relatively stable over the past few quarters.
*   **Profit Margin:** Profit margins are high, indicating strong operational efficiency.
*   **Equity:** Equity has generally increased.
*   **ROE:** Return on Equity has fluctuated, with a significant spike in 2025-03-31.

### 7. Overall Summary

Based on the provided data, here's a concise summary of JNJ:

*   **Underperformance:** JNJ has significantly underperformed the S&P 500 over the analyzed period and is expected to continue to do so based on the negative expected return.
*   **Financial Strength:**  The company maintains strong revenue, high profit margins, and a growing equity base.
*   **Technicals:** The stock is currently overbought based on RSI, and recent news suggests potential volatility.
*   **Risk:** While the Market Risk Indicator suggests low market risk, the significant Maximum Drawdown values indicate potential for substantial losses.

**Conclusion:** While JNJ demonstrates financial stability and strong profitability, its underperformance relative to the broader market, particularly as highlighted by the negative expected return, is a significant concern. The technical indicators suggest caution in the short term. Recent news events also warrant close monitoring.
